DrugPatentWatch Database Preview
Acadia Pharms Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ACADIA PHARMS INC, and when can generic versions of ACADIA PHARMS INC drugs launch?
ACADIA PHARMS INC has two approved drugs.
There are sixteen US patents protecting ACADIA PHARMS INC drugs.
There are one hundred and thirty-one patent family members on ACADIA PHARMS INC drugs in twenty-seven countries.
Summary for Acadia Pharms Inc
| International Patents: | 131 |
| US Patents: | 16 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Acadia Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-002 | Jun 28, 2018 | RX | Yes | Yes | 7,601,740 | Start Trial | Y | Y | Start Trial | ||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-001 | Apr 29, 2016 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-002 | Jun 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | CAPSULE;ORAL | 210793-001 | Jun 28, 2018 | RX | Yes | Yes | 7,858,789 | Start Trial | Y | Y | Start Trial | ||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-001 | Apr 29, 2016 | DISCN | Yes | No | 7,858,789 | Start Trial | Y | Y | Start Trial | ||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-002 | Jun 28, 2018 | RX | Yes | Yes | 7,659,285 | Start Trial | Start Trial | ||||
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-001 | Apr 29, 2016 | DISCN | Yes | No | 8,110,574 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Acadia Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2010174026 | Start Trial |
| China | 101500568 | Start Trial |
| South Korea | 20070083800 | Start Trial |
| France | 2802206 | Start Trial |
| China | 101778821 | Start Trial |
| Russian Federation | 2007115886 | Start Trial |
| Australia | 4007201 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
